Drug Type Small molecule drug |
Synonyms ALV 2007, ALV2007 |
Target |
Action antagonists |
Mechanism Integrin antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis, Liver | Preclinical | United Kingdom | 01 Nov 2024 | |
Neoplasms | Preclinical | United Kingdom | 01 Nov 2024 | |
Renal fibrosis | Preclinical | United Kingdom | 01 Nov 2024 |